These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11874898)

  • 61. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.
    Mitchell LA; Ochnio JJ; Glover C; Lee AY; Ho MK; Bell A
    J Infect Dis; 1996 Apr; 173(4):1009-13. PubMed ID: 8603941
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.
    McVernon J; MacLennan J; Pollard AJ; Oster P; Wakefield MJ; Danzig L; Moxon ER
    Pediatr Infect Dis J; 2003 Jul; 22(7):659-61. PubMed ID: 12886896
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.
    de Whalley PC; Snape MD; Kelly DF; Banner C; Lewis S; Diggle L; John TM; Yu LM; Omar O; Borkowski A; Pollard AJ
    Pediatr Infect Dis J; 2011 Nov; 30(11):e203-8. PubMed ID: 21673612
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults.
    Deeks ED
    BioDrugs; 2010 Oct; 24(5):287-97. PubMed ID: 20795751
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 67. The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.
    Fijen CA; Bredius RG; Kuijper EJ; Out TA; De Haas M; De Wit AP; Daha MR; De Winkel JG
    Clin Exp Immunol; 2000 May; 120(2):338-45. PubMed ID: 10792385
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune response of infants and children to disseminated infections with Neisseria meningitidis.
    Griffiss JM; Brandt BL; Broud DD; Goroff DK; Baker CJ
    J Infect Dis; 1984 Jul; 150(1):71-9. PubMed ID: 6431015
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Flow Cytometric Assays to Quantify fHbp Expression and Detect Serotype Specific Capsular Polysaccharides on Neisseria meningitidis.
    Loschko J; Garcia K; Cooper D; Pride M; Anderson A
    Methods Mol Biol; 2019; 1969():217-236. PubMed ID: 30877680
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
    Trotter CL; Ramsay ME
    FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of antigen coating conditions on enzyme-linked immunosorbent assay for detection of immunoglobulin G antibody to Neisseria meningitidis serogroup Y and W135 capsular polysaccharide antigens in serum.
    Giardina PC; Evans RE; Sikkema DJ; Madore D; Hildreth SW
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1136-40. PubMed ID: 14607879
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The bactericidal action of human neutrophils on meningococci in vitro].
    Platonov AE; Vershinina IV; Käyhty H; Fijen CA; Kuijper EJ
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):46-52. PubMed ID: 10851990
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Improved antiserum agar method for the serogroup differentiation of Neisseria meningitidis Y and W135.
    Ashton FE; Ryan A; Diena BB
    Can J Microbiol; 1980 May; 26(5):630-2. PubMed ID: 6772290
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes.
    Craven DE; Shen KT; Frasch CE
    Infect Immun; 1982 Jul; 37(1):132-7. PubMed ID: 6809622
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development and characterization of anti-idiotype based peptide and DNA vaccines which mimic the capsular polysaccharide of Neisseria meningitidis serogroup C.
    Westerink MA; Smithson SL; Hutchins WA; Widera G
    Int Rev Immunol; 2001; 20(2):251-61. PubMed ID: 11878768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines.
    González E; Reyes F; Otero O; Camacho F; Cuello M; Ramírez F; Acevedo R
    Methods Mol Biol; 2019; 1969():181-203. PubMed ID: 30877678
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ex vivo bactericidal activity against group C Neisseria meningitidis in seronegative subjects.
    Gómez-Lus ML; Aguilar L; Vázquez J; Giménez MJ; Ruiz G; Berrón S; Fuentes F; Prieto J
    Infection; 2000 Sep; 28(5):305-8. PubMed ID: 11073138
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after immunization with outer membrane vesicle of Neisseria meningitidis serogroup B.
    Siadat SD; Kheirandish M; Norouzian D; Behzadiyannejad Q; Najar Peerayeh S; Zangeneh M; Nejati M
    Pak J Biol Sci; 2007 Oct; 10(20):3578-84. PubMed ID: 19093465
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of natural immunity to Neisseria meningitidis.
    Pollard AJ; Frasch C
    Vaccine; 2001 Jan; 19(11-12):1327-46. PubMed ID: 11163654
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Flow cytometric quantitation of human opsonin-dependent phagocytosis and oxidative burst responses to meningococcal antigens.
    Lehmann AK; Halstensen A; Bassøe CF
    Cytometry; 1998 Dec; 33(4):406-13. PubMed ID: 9845434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.